Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New in-vitro fertilisation (IVF) code recommends cystic fibrosis (CF) screening for donors:

This article was originally published in Clinica

Executive Summary

All sperm and egg donors in the UK should be tested to determine whether they are carriers of the cystic fibrosis gene, says the Human Fertilisation and Embryology Authority in an updated code of practice to be published early next year. It recommends that tests of donors should only be for recessive disorders and recipients should be told. Donors are already screened for diseases including HIV, Hepatitis B and C, and syphilis. The code guides private clinics on how they should carry out their activities.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel